FilingReader Intelligence
Indoco Remedies reports 12.5% quarterly revenue growth
July 28, 2025 at 06:19 AM UTC•By FilingReader AI
Indoco Remedies reported consolidated net revenues of Rs. 4,291 million for Q1 FY26, a 12.5% growth from the preceding quarter.
The OTC business saw 46% quarter-on-quarter growth. International business increased by over 26%, with European authorities approving a plant for sterile product supply.
The company plans approximately Rs. 68 crore in loan repayments over the next nine months.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:INDOCO•Bombay Stock Exchange
News Alerts
Get instant email alerts when Indoco Remedies publishes news
Free account required • Unsubscribe anytime